These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

400 related items for PubMed ID: 17713111

  • 1. [Investigation of the effect of vinpocetine on cerebral blood flow and cognitive functions].
    Valikovics A.
    Ideggyogy Sz; 2007 Jul 30; 60(7-8):301-10. PubMed ID: 17713111
    [Abstract] [Full Text] [Related]

  • 2. [Study of the effects of vinpocetin on cognitive functions].
    Valikovics A, Csányi A, Németh L.
    Ideggyogy Sz; 2012 Mar 30; 65(3-4):115-20. PubMed ID: 23136730
    [Abstract] [Full Text] [Related]

  • 3. Transcranial Doppler assessment of cerebral vasomotor reactivity in evaluating the effects of vinpocetine in cerebral small vessel disease: a pilot study.
    Jovanović ZB, Pavlović AM, Pekmezović T, Mijajlović M, Covicković NS.
    Ideggyogy Sz; 2013 Jul 30; 66(7-8):263-8. PubMed ID: 23971358
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. [The use of vinpocetine in chronic disorders caused by cerebral hypoperfusion].
    Horváth S.
    Orv Hetil; 2001 Feb 25; 142(8):383-9. PubMed ID: 11263076
    [Abstract] [Full Text] [Related]

  • 6. Role of vinpocetine in cerebrovascular diseases.
    Patyar S, Prakash A, Modi M, Medhi B.
    Pharmacol Rep; 2011 Feb 25; 63(3):618-28. PubMed ID: 21857073
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. [Vinpocetin in neurological diseases].
    Szapáry L, Késmárky G, Tóth K, Misnyovszky M, Tóth T, Balogh A, Nagy K, Németh GY, Fehér G.
    Ideggyogy Sz; 2012 Nov 30; 65(11-12):387-93. PubMed ID: 23289173
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Protective effect of vinpocetine against brain damage caused by ischemia.
    Rischke R, Krieglstein J.
    Jpn J Pharmacol; 1991 Jul 30; 56(3):349-56. PubMed ID: 1895579
    [Abstract] [Full Text] [Related]

  • 12. Asymptomatic ischemic cerebrovascular disorders and neuroprotection with vinpocetine.
    Hadjiev D.
    Ideggyogy Sz; 2003 May 20; 56(5-6):166-72. PubMed ID: 12861957
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Acute and chronic effects of vinpocetine on cerebral hemodynamics and neuropsychological performance in multi-infarct patients.
    Kemény V, Molnár S, Andrejkovics M, Makai A, Csiba L.
    J Clin Pharmacol; 2005 Sep 20; 45(9):1048-54. PubMed ID: 16100299
    [Abstract] [Full Text] [Related]

  • 19. [An effect of vinpocetine (cavinton) on endothelium function in patients with chronic cerebral ischemia].
    Vaizova OE, Vengerovskiĭ AI, Alifirova VM.
    Zh Nevrol Psikhiatr Im S S Korsakova; 2006 Sep 20; Suppl 16():46-50. PubMed ID: 18196635
    [Abstract] [Full Text] [Related]

  • 20. [Effect of vinpocetin on the hemorheologic parameters in patients with chronic cerebrovascular disease].
    Szapáry L, Horváth B, Alexy T, Márton Z, Késmárky G, Szóts M, Nagy F, Czopf J, Tóth K.
    Orv Hetil; 2003 May 18; 144(20):973-8. PubMed ID: 12830727
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 20.